ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,102Medicare Part D Prescriptions Filled, Including Refills

Rank: 333 out of 6645

$673K Total Retail Price of All Prescriptions

Rank: 691 out of 6645

298 Patients Receiving at Least One Drug in Part D
99%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 298 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

26% of this provider’s 298 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

0% of this provider’s 15,014 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

51 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
WARFARIN SODIUM 969 969 1 16
LEVOTHYROXINE SODIUM 761 761 2 4
FUROSEMIDE 634 634 3 11
SIMVASTATIN 528 519 4 1
HYDROCODONE-ACETAMINOPHEN 467 464 S3 5 5
OMEPRAZOLE 449 448 6 6
LISINOPRIL 438 432 7 3
MIRTAZAPINE 400 400 8 70
NAMENDA 364 361 9 41
GABAPENTIN 340 340 10 18
POTASSIUM CHLORIDE 331 331 11 28
AMLODIPINE BESYLATE 255 251 12 2
METOPROLOL TARTRATE 242 242 13 13
GLIPIZIDE 238 238 14 23
LANTUS 203 202 15 50
DIVALPROEX SODIUM 197 197 16 113
PANTOPRAZOLE SODIUM 197 197 16 29
CARVEDILOL 196 196 18 25
TRAZODONE HCL 185 184 19 60
QUETIAPINE FUMARATE 175 174 20 101
ESCITALOPRAM OXALATE 168 168 21 86
ATORVASTATIN CALCIUM 154 154 22 10
FLUTICASONE PROPIONATE 138 138 23 26
TAMSULOSIN HCL 135 135 24 22
LIDODERM 133 133 25 53
ZOLPIDEM TARTRATE 131 122 26 17
FENTANYL 129 129 S2 27 141
DIOVAN 124 124 28 19
CARBIDOPA-LEVODOPA 124 124 28 116
CITALOPRAM HBR 123 123 30 35
NOVOLOG 122 122 31 144
IPRATROPIUM BROMIDE 120 120 32 156
CLOPIDOGREL 119 112 33 36
TRAVATAN Z 119 119 33 342
SPIRONOLACTONE 116 116 35 85
HYDRALAZINE HCL 106 106 36 77
DIGOXIN 101 101 37 59
PAROXETINE HCL 99 99 38 72
TIMOLOL MALEATE 97 97 39 373
SERTRALINE HCL 94 93 40 43
LOSARTAN POTASSIUM 94 94 40 12
PREDNISONE 93 93 42 57
PLAVIX 87 85 43 49
DILTIAZEM 24HR ER 86 86 44 187
ALENDRONATE SODIUM 85 85 45 14
NYSTOP 80 77 46 348
ALBUTEROL SULFATE 79 79 47 112
DONEPEZIL HCL 79 79 47 27
NYSTATIN 79 79 47 234
CLONIDINE HCL 77 77 50 56
FLUOXETINE HCL 74 59 51 63
CYMBALTA 70 70 52 78
SEROQUEL 69 69 53 208
CEPHALEXIN 68 68 54 111
TRIAMCINOLONE ACETONIDE 64 64 55 55
NYSTATIN-TRIAMCINOLONE 63 63 56 346
FAMOTIDINE 58 58 57 33
VENLAFAXINE HCL ER 57 57 58 175
LABETALOL HCL 55 55 59 226
RISPERIDONE 52 52 60 93
LIPITOR 52 52 60 69
ATENOLOL 51 51 62 8
POLYETHYLENE GLYCOL 3350 51 51 62 121
PREDNISOLONE ACETATE 50 50 64 487
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.